Sartorius neemt vloeistofbehandelingsdivisie van Biohit over
Array
Sartorius, toonaangevend internationaal leverancier van proces- en laboratoriumtechnologie, heeft de overname afgerond van de vloeistofbehandelingsdivisie van de Finse producent van laboratoriumproducten Biohit Oyj. De transactie werd op 26 october j.l. aangekondigd. Met deze overname volgt Sartorius zijn strategie ter uitbreiding van zijn productaanbod van laboratoriumapplicaties. Mechanische en elektronische pipetten zijn typische kleine instrumenten die het meest frequent in laboratoria gebruikt worden.
Tot dusver leverde het bedrijf zijn klanten in dit segment voornamelijk laboratoriumweegschalen, waterzuiveringsinstallaties, vochtanalysatoren en verbruiksproducten voor monsterpreparatie. Als resultaat van de overname vertegenwoordigt het laboratoriumsegment van Sartorius ongeveer een derde van de toekomstige verkoop van het concern.
Engelstalig bericht:
Sartorius Closes Acquisition of the Biohit Liquid Handling Business
- Significant expansion of the Sartorius product portfolio for laboratories
- Integration process has begun
Yesterday Sartorius, a leading international process and laboratory technology provider, successfully completed its acquisition of the liquid handling business of the Finnish laboratory supplier Biohit Oyj. The transaction had been announced on October 26, 2011.
With this purchase, Sartorius is pursuing its strategy to expand its product offering for laboratory applications. Mechanical and electronic pipettes are among the types of small instrumentation most frequently used in laboratories. So far, the company has been offering its customers in this segment primarily laboratory balances, laboratory water purification systems, moisture analyzers and consumables for sample preparation. As a result of this acquisition, the Sartorius laboratory business will represent around one third of the Group’s future sales. The larger Sartorius Biotechnology division supplies products and services for the manufacture of biopharmaceuticals.
“The liquid handling business will make an important contribution to the growth strategy of our laboratory unit,†comments Dr. Joachim Kreuzburg, CEO of Sartorius AG. “I am pleased that we have closed this acquisition as fast as planned. Our first priority in the integration process is to rapidly offer our customers the entire range of products and services with the same high quality we’re known for, all from a single source.â€
This press release contains statements about the future development of the Sartorius Group. The content of these statements cannot be guaranteed as they are based on assumptions and estimates that harbor certain risks and uncertainties.
This is a translation of the original German-language press release. Sartorius shall not assume any liability for the correctness of this translation. The original German press release is the legally binding version. Furthermore, Sartorius reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.
Photos
http://www.sartorius.com/media/content/press/support/kreuzburg.jpg
Dr. Joachim Kreuzburg, CEO and Executive Board Chairman of Sartorius AG
http://www.sartorius.com/media/content/press/support/laboratory.jpg
Sartorius continues to expand its laboratory business
A Profile of Biohit Liquid Handling
The acquisition covers all assets of the liquid handling segment of Biohit Oyj, including its production facilities in Finland and China, as well as its sales subsidiaries in eight countries. This liquid handling segment is one of the global market leaders for mechanical and electronic pipettes, as well as for the associated consumables. The Biohit liquid handling segment, which employs some 400 people, generated net sales of approximately 38 million euros and an EBITDA margin of around 13% in fiscal 2010. Its major customers are research, quality assurance and academic laboratories as well as hospitals. The purchase price was 68 million euros.
A Profile of Sartorius
The Sartorius Group (FWB:SRT) is a leading international laboratory and process technology provider covering the segments of biotechnology and mechatronics. In 2010, the technology group earned sales revenue of 659.3 million euros. Founded in 1870, the Goettingen-based company currently employs more than 4,500 persons. The major areas of activity in its biotechnology segment focus on filtration, fluid management, fermentation and cell cultivation, purification and laboratory applications. In the mechatronics segment, the company primarily manufactures equipment and systems featuring weighing, measurement and automation technology for laboratory and industrial applications. Key Sartorius customers are from the pharmaceutical, chemical and food industries and from numerous research and educational institutes of the public sector. Sartorius has its own production facilities in Europe, Asia and America as well as sales subsidiaries and local commercial agencies in more than 110 countries.
More information: www.sartorius.com.
Petra Kirchhoff
Vice President of Corporate Communications
Phone             +49 (0)551.308.1686
[email protected]
